Jim Cramer Says He’d Take KeyCorp Over Truist in CNBC Lightning Round Despite the Noise, Truist's Keith Lerner Says Bulls Still Have the Upper Hand Navigating Choppy Waters: Truist's Keith Lerner Sees More Market Correction Ahead Truist Ignites Excitement: Janux Therapeutics Stock Receives Bold 'Buy' Rating on Promising H2 Catalysts